Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)

被引:34
|
作者
Jayatunga, Madura K. P. [1 ]
Thompson, Sam [1 ]
McKee, Tawnya C. [2 ]
Chan, Mun Chiang [1 ]
Reece, Kelie M. [3 ]
Hardy, Adam P. [1 ]
Sekirnik, Rok [1 ]
Seden, Peter T. [1 ]
Cook, Kristina M. [3 ]
McMahon, James B. [2 ]
Figg, William D. [3 ]
Schofield, Christopher J. [1 ]
Hamilton, Andrew D. [1 ]
机构
[1] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England
[2] Ctr Canc Res, Mol Targets Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA
[3] NCI, Mol Pharmacol Sect, Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院; 英国惠康基金;
关键词
Hypoxia; HIF; p300/CBP; Zinc ejection; Electrophile; Quinone; HYPOXIA-INDUCIBLE TRANSCRIPTION; ENDOTHELIAL GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; DNA-BINDING; FACTOR-I; FACTOR; 1-ALPHA; TUMOR-GROWTH; PROTEIN; HIF-1; HYDROQUINONE;
D O I
10.1016/j.ejmech.2014.06.006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein-protein interactions between the hypoxia inducible factor (HIF) and the transcriptional coactivators p300/CBP are potential cancer targets due to their role in the hypoxic response. A natural product based screen led to the identification of indandione and benzoquinone derivatives that reduce the tight interaction between a HIF-1 alpha fragment and the CH1 domain of p300. The indandione derivatives were shown to fragment to give ninhydrin, which was identified as the active species. Both the naphthoquinones and ninhydrin were observed to induce Zn(II) ejection from p300 and the catalytic domain of the histone demethylase KDM4A. Together with previous reports on the effects of related compounds on HIF-1 alpha and other systems, the results suggest that care should be taken in interpreting biological results obtained with highly electrophilic/thiol modifying compounds. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 42 条
  • [1] Potent Inhibition of HIF1α and p300 Interaction by a Constrained Peptide Derived from CITED2
    Qin, Xuan
    Chen, Hailing
    Tu, Licheng
    Ma, Yue
    Liu, Na
    Zhang, Haowei
    Li, Di
    Riedl, Bernd
    Bierer, Donald
    Yin, Feng
    Li, Zigang
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (18) : 13693 - 13703
  • [2] Select epidithiodiketopiperazine (ETP) compounds disrupt the HIF-1α/p300 interaction and HIF-mediated transcription
    Richardson, Emily D.
    Reece, Kelie M.
    Campbell, Tessa J.
    Pressler, Heather
    Pisle, Stephen T.
    Figg, William D.
    CANCER RESEARCH, 2012, 72
  • [3] A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1α and p300/CBP through Direct Binding to the HIF1α C-Terminal Activation Domain
    Wu, Donglu
    Zhang, Rui
    Zhao, Rui
    Chen, Guang
    Cai, Yong
    Jin, Jingji
    PLOS ONE, 2013, 8 (05):
  • [4] Disruption of the HIF-1α/p300 interaction as a means of inhibiting angiogenesis
    Reece, Kelie M.
    Richardson, Emily D.
    Pisle, Stephen T.
    Holly, Alesia J.
    Campbell, Tessa J.
    Figg, William D.
    FASEB JOURNAL, 2012, 26
  • [5] Epidithiodiketopiperazines Block the Interaction between Hypoxia-inducible Factor-1α (HIF-1α) and p300 by a Zinc Ejection Mechanism
    Cook, Kristina M.
    Hilton, Stephen T.
    Mecinovic, Jasmin
    Motherwell, William B.
    Figg, William D.
    Schofield, Christopher J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (39) : 26831 - 26838
  • [6] Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia:: their stabilization and redox signal-induced interaction with CBP/p300
    Ema, M
    Hirota, K
    Mimura, J
    Abe, H
    Yodoi, J
    Sogawa, K
    Poellinger, L
    Fujii-Kuriyama, Y
    EMBO JOURNAL, 1999, 18 (07): : 1905 - 1914
  • [7] Synthetic modulation of the hypoxic response in cancer through inhibition of the HIF-1a/p300 protein-protein interaction
    Jayatunga, Madura K. P.
    Thompson, Sam
    Hardy, Adam
    Schofield, Chris J.
    Hamilton, Andrew D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [8] Isolation and identification of novel natural products that inhibit P300/HIF-1α interaction
    Chan, S. T. S.
    Patel, P. R.
    Martin, G. E.
    Williamson, R. T.
    Sauri, J.
    Buevich, A., V
    Ransom, T. R.
    Henrich, C. J.
    McKee, T. C.
    Figg, W. D.
    McMahon, J. B.
    Schnermann, M. J.
    Gustafson, K. R.
    PLANTA MEDICA, 2015, 81 (11) : 909 - 909
  • [9] Novel mechanism for tumor inhibition revealed by the structure of the HIF-1α/p300 complex.
    Freedman, S
    Sun, ZYJ
    Poy, F
    Kung, AL
    Livingston, DM
    Wagner, G
    Eck, MJ
    BLOOD, 2001, 98 (11) : 830A - 830A
  • [10] Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction
    Yang, Chao
    Wang, Wanhe
    Li, Guo-Dong
    Zhong, Hai-Jing
    Dong, Zhen-Zhen
    Wong, Chun-Yuen
    Kwong, Daniel W. J.
    Ma, Dik-Lung
    Leung, Chung-Hang
    SCIENTIFIC REPORTS, 2017, 7